Advertisement

Topics

ILEX Oncology Company Profile

21:18 EST 19th November 2017 | BioPortfolio

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product candidates. The pipeline comprises multiple technologies at all stages of clinical development, including a monoclonal antibody, apoptosis-inducing agents, cytotoxic compounds with novel mechanisms of action, angiogenesis inhibitors and chemoprevention agents.

Location

11550 IH 10 West
San Antonio
TX
78230
United States of America


News Articles [353 Associated News Articles listed on BioPortfolio]

BTG, SIO expand immuno─oncology/interventional oncology research grant programme

BTG, a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, have expa...

Ockham Oncology’s CSO highlights global strength of fully integrated company.

Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Ne...

Oncology Information System Market by Products and Services Software and Services, Application Radiation Oncology, Medical Oncology, and Surgical Oncology, and End Users Hospitals and Oncology Clinics and Research Centers Global Opportunity Analysis and

Oncology information systems is a software that is used to manage extensive cancer patient data and oversee procedures associated with oncology care. The advantages of using oncology information syste...

Axel Hoos, GSK: Focusing on immuno-oncology and cancer epigenetics

GSK has had a recent change in Oncology after recently divesting their marketed oncology products to Novartis whilst retaining their R&D pipeline. During BIO 2015, Axel Hoos, VP Oncology R&D at GSK ex...

Veeva Systems launches Veeva Oncology Link

Veeva Systems announced Veeva Oncology Link, an enterprise data solution to centralize insights and intelligence on scientific leaders in oncology. Veeva Oncology Link consolidates thousands of global...

Champions Oncology, AstraZeneca collaborate

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, announced a strategic collabor...

Is immuno-oncology shaping the oncology product development landscape?

Steven Powell, chief executive of UK-based immuno-oncology (I-O) company Macrophage Pharma, gives an…

License Agreement: Clovis Oncology $CLVS (Ethical Oncology Science, S.p.A, Servier, SA, and Advenchen Laboratories, LLC)

November 2013, Clovis Oncology ($CLVS @ClovisOncology) acquired Ethical Oncology Science, S.p.A. (“EOS”) (known as Clovis Oncology Italy S.r.l., or “COI”) through which the rights to lucitani...

PubMed Articles [1482 Associated PubMed Articles listed on BioPortfolio]

Changes in phytochemical composition, bioactivity and in vitro digestibility of Guayusa leaves (Ilex guayusa Loes.) in different ripening stages.

Guayusa (Ilex guayusa Loes.) leaves, native of the Ecuadorian amazon, are popularly used for preparing teas. This study aimed to assess the influence of leaf age on the phenolic compounds and caroteno...

Increasing carbon discrimination rates and depth of water uptake favor the growth of Mediterranean evergreen trees in the ecotone with temperate deciduous forests.

Tree populations at the low-altitudinal or -latitudinal limits of species' distributional ranges are predicted to retreat toward higher altitudes and latitudes to track the ongoing changes in climate....

Short-term consumption of Ilex paraguariensis extracts protects isolated hearts from ischemia/reperfusion injury and contradicts exercise-mediated cardioprotection.

Perfusion of hearts with extracts of Ilex paraguariensis (IP/mate) appears to reduce ischemia/reperfusion (I/R) injury. To determine if oral consumption of IP/mate can provide similar cardioprotection...

Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.

Older adults compose the majority of patients with cancer in the United States; however, it is unclear how well geriatrics or geriatric oncology training is being incorporated into hematology-oncology...

Functional indicators of response mechanisms to nitrogen deposition, ozone, and their interaction in two Mediterranean tree species.

The effects of nitrogen (N) deposition, tropospheric ozone (O3) and their interaction were investigated in two Mediterranean tree species, Fraxinus ornus L. (deciduous) and Quercus ilex L. (evergreen)...

Clinical Trials [412 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Yerba Mate (Ilex Paraguariensis A.St.-Hil.): Assessment of Cardiovascular Health

Mate or yerba-mate (Ilex paraguariensis A.St.-Hil.) is a native plant from South America highly consumed in this region. Different traditional products (mate, mate tea, chimarrao, tereré)...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Survivorship Care Plans in a Community Oncology Practice

This is a two part observational study evaluating the feasibility of implementing an EHR-based model within a community oncology practice.

Companies [687 Associated Companies listed on BioPortfolio]

ILEX Oncology

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product...

ILEX Oncology Incorporated

ILEX Oncology, Inc. is a drug development company focused exclusively on accelerated development of drugs for thetreatment and prevention of cancer. The Company uses its expertise in the identificatio...

Tessman Technology Limited

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Test-Mall

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Boston Millennia Partners

Boston Millennia Partners is a private equity investment partnership managing over $700 million in capital. Millennia invests in high-growth businesses in the healthcare and busin...

More Information about "ILEX Oncology" on BioPortfolio

We have published hundreds of ILEX Oncology news stories on BioPortfolio along with dozens of ILEX Oncology Clinical Trials and PubMed Articles about ILEX Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ILEX Oncology Companies in our database. You can also find out about relevant ILEX Oncology Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record